Published in Curr Rheumatol Rep on July 01, 2008
Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells. Circulation (2008) 1.35
Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology (2009) 1.16
Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB. Invest Ophthalmol Vis Sci (2012) 0.94
Endothelial progenitor cell dysfunction in rheumatic disease. Nat Rev Rheumatol (2009) 0.88
Lymphatic and blood vessels in scleroderma skin, a morphometric analysis. Hum Pathol (2009) 0.82
Increased CD40+ Fibrocytes in Patients With Idiopathic Orbital Inflammation. Ophthal Plast Reconstr Surg (2015) 0.75
Cutaneous Connective Tissue Diseases: Epidemiology, Diagnosis, and Treatment. Open Dermatol J (2009) 0.75
Silica promotes the transdifferentiation of rat circulating fibrocytes in vitro. Mol Med Rep (2015) 0.75
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16
Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med (1994) 7.19
Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol (2003) 4.69
Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol (2003) 4.35
Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res (2000) 3.64
The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest (2007) 3.15
Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol (1998) 3.09
Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation (2001) 2.95
Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A (2006) 2.85
Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol (2003) 2.67
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun (2006) 2.52
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med (2001) 2.47
Defective vasculogenesis in systemic sclerosis. Lancet (2004) 2.38
HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest (2001) 2.20
Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. Arthritis Rheum (2006) 2.19
Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med (2004) 2.17
A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A (2003) 2.09
Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol (2007) 2.02
Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J (2001) 1.91
Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol (2005) 1.84
Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med (2007) 1.67
Endothelial progenitor cells as putative targets for angiostatin. Cancer Res (1999) 1.63
Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen (2007) 1.56
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res (2002) 1.52
Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol (2004) 1.52
Normal circulating serum amyloid P component concentration in systemic sclerosis. Arthritis Rheum (2007) 1.42
How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther (2007) 1.40
Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum (2006) 1.30
Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology (1995) 1.25
Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis (2006) 1.25
Adult stem cells in the treatment of autoimmune diseases. Rheumatology (Oxford) (2006) 1.18
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum (2007) 1.18
Endothelial progenitor cells for vasculogenesis. Physiology (Bethesda) (2005) 1.18
Levels of circulating endothelial progenitor cells in systemic sclerosis. Clin Exp Rheumatol (2007) 1.11
Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium. Adv Dermatol (2007) 1.05
4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cells. Leuk Res (1985) 1.04
Improvement in postburn hypertrophic scar after treatment with IFN-alpha2b is associated with decreased fibrocytes. J Interferon Cytokine Res (2007) 0.97
Cell therapy for autoimmune diseases. Arthritis Res Ther (2007) 0.95
Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol (2004) 0.95
Antiangiogenic plasma activity in patients with systemic sclerosis. Arthritis Rheum (2007) 0.94
High-dose cyclophosphamide without stem cell rescue in scleroderma. Ann Rheum Dis (2007) 0.93
CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma. Arch Dermatol (1994) 0.93
Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy. Cell Biol Toxicol (2007) 0.91
Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. Arthritis Rheum (2003) 0.91
Gene modified cell transplantation for vascular regeneration. Curr Gene Ther (2007) 0.86
Adult stem cell treatment of scleroderma. Curr Opin Rheumatol (2007) 0.81
Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma. Clin Rheumatol (2006) 0.81
Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients. Haematologica (1991) 0.77
Novel paradigm for treating vasculopathy in systemic sclerosis: vascular progenitor cells and statins. Curr Rheumatol Rep (2007) 0.76